Andersons vs Ingredion
ANDE and INGR side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ANDE and INGR compare
Ingredion is the larger company, worth 3.3 times as much as Andersons ($5.7B against $1.8B).
On earnings, Ingredion is cheaper: it trades at 9.9× trailing earnings, against 10.1× for Andersons.
Ingredion grew revenue faster over the last twelve months (−1.4% versus −5.2% for Andersons).
Ingredion keeps more of each dollar of sales as profit, with a net margin of 8.2% compared with 1.6% at Andersons.
Both pay dividends: Andersons yields 1.5% and Ingredion 3.6%.
Ingredion scores higher on the StockData Score (20 against 19 for Andersons), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ANDE | INGR |
|---|---|---|
| Size and price | ||
| Market cap | $1.8B | $5.7B |
| Share price | $52.02 | $91.11 |
| Change, 1 year | 5.6% | −15.4% |
| Change, 5 years | 47.8% | −5.7% |
| Beta (5Y) | −0.55 | 0.33 |
| Employees | 2,137 | 11K |
| StockData Score | ||
| Total score | 19 | 20 (better) |
| Valuation score | 5 | 6 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 4 | 5 (better) |
| Health score | 4 | 5 (better) |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 10.1× | 9.9× (better) |
| P/S | 0.2× (better) | 0.8× |
| P/B | 1.3× | 1.3× (better) |
| EV/EBITDA | – | 6.1× |
| P/FCF | 31.1× | 16.2× (better) |
| PEG | – | 0.66 |
| FCF yield | 3.2% | 6.2% (better) |
| Fair value | $104.51 | $163.78 |
| Margin of safety | 50.2% (better) | 44.4% |
| Growth | ||
| Revenue growth (TTM) | −5.2% | −1.4% (better) |
| Revenue growth, 5Y average | 6.4% (better) | 3.8% |
| Net income growth (TTM) | 120% (better) | −12.4% |
| EPS growth (TTM) | 120% (better) | −10.5% |
| EPS growth, 5Y average | – | 16.8% |
| Profitability | ||
| Gross margin | 7.2% | 23.7% (better) |
| Operating margin | – | 11.9% |
| Net margin | 1.6% | 8.2% (better) |
| FCF margin | 0.52% | 4.9% (better) |
| Return on equity | 13.2% | 13.6% (better) |
| Return on invested capital | – | 12.0% |
| Financial health | ||
| Debt / equity | 0.68 | 0.39 (better) |
| Net debt / EBITDA | – | 0.77 |
| Current ratio | 1.51 | 2.80 (better) |
| Altman Z-score | 4.34 (better) | 3.57 |
| Piotroski F-score | 4 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.5% | 3.6% (better) |
| Payout ratio | 15.3% | 35.5% |
| Years of dividend growth | 16 | – |
| Dividend growth, 5Y average | 2.3% | – |
| Shareholder yield | 1.5% | 3.6% (better) |
| Ownership | ||
| Held by institutions | 89.7% | 98.9% |
| Held by insiders | 4.3% | 0.83% |
| Insider net buying, 12 months | −$9.8M | −$6.0M (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 4.3% | 7.3% |
Go deeper
- ANDE stock overview
- ANDE income statement
- ANDE valuation and score
- INGR stock overview
- INGR income statement
- INGR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.